[H.E.L.P. (heparin-induced extracorporeal LDL precipitation) and bezafibrate--a new therapeutic combination in cerebrovascular diseases].
Walzl
M
M
Universitätsklinik für Neurologie Graz.
Walzl
B
B
Kleinert
G
G
Schied
H
H
Lechner
H
H
D000368:Aged; D001629:Bezafibrate / Q000008:administration & dosage*; D001809:Blood Viscosity / Q000502:physiology; D011232:Chemical Precipitation; D003131:Combined Modality Therapy; D015161:Dementia, Multi-Infarct / Q000097:blood / Q000628:therapy*; D004311:Double-Blind Method; D005340:Fibrinogen / Q000032:analysis; D006464:Hemoperfusion / Q000295:instrumentation*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood*; D009483:Neuropsychological Tests; D010956:Plasmapheresis / Q000295:instrumentation*; D014280:Triglycerides / Q000097:blood
D008077:Lipoproteins, LDL; D014280:Triglycerides; D005340:Fibrinogen; D006493:Heparin; D001629:Bezafibrate
H.E.L.P. und Bezafibrat--eine neue therapeutische Kombination bei zerebrovaskulären Erkrankungen.